SCHEMBL6664624

SCHEMBL6664624

O=c1nc(C(F)(F)F)cc(C=Cc2ccc(-c3ccc(F)c(Cl)c3)o2)[nH]1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PSD A5PKW4 1/20 0.52
▸ MEN1 O00255 3/20 0.50
▸ KMT2A Q03164 3/20 0.50
▸ POLB P06746 3/20 0.50
▸ HPGD P15428 2/20 0.50
▸ LMNA P02545 1/20 0.50
▸ MAPT P10636 1/20 0.50
▸ IGF1R P08069 2/20 0.46
▸ ALDH1A1 P00352 4/20 0.42
▸ KDM4E B2RXH2 3/20 0.42
▸ USP2 O75604 2/20 0.42
▸ CRHBP P24387 1/20 0.42
▸ CRHR2 Q13324 1/20 0.42
▸ L3MBTL1 Q9Y468 1/20 0.42
▸ RPA1 P27694 1/20 0.40
▸ HTT P42858 1/20 0.38
▸ RECQL P46063 1/20 0.38
▸ TLR9 Q9NR96 1/20 0.38
▸ NPC1 O15118 1/20 0.36
▸ RAB9A P51151 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16211020 0.87 PSD (0.55) PSDMEN1KMT2APOLBHPGD
SCHEMBL16211019 0.87 PSD (0.55) PSDMEN1KMT2APOLBHPGD
SCHEMBL6668285 0.83 MEN1 (0.52) PSDMEN1KMT2APOLBHPGD
SCHEMBL13479595 0.83 MEN1 (0.53) PSDMEN1KMT2APOLBHPGD
SCHEMBL6596295 0.82 PSD (0.77) PSDMEN1KMT2APOLBHPGD
SCHEMBL6596299 0.82 PSD (0.77) PSDMEN1KMT2APOLBHPGD
SCHEMBL6591626 0.81 KDM4E (0.55) PSDMEN1KMT2APOLBHPGD
SCHEMBL6591623 0.81 KDM4E (0.55) PSDMEN1KMT2APOLBHPGD
SCHEMBL6664657 0.80 MEN1 (0.50) PSDMEN1KMT2APOLBHPGD
SCHEMBL6684366 0.80 KMT2A (0.46) PSDMEN1KMT2APOLBHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004016271-A1 PYRIMIDONES AS ANTIVIRAL AGENTS AXXIMA PHARMACEUTICALS AG (DE) 2004-02-26 — — WO disclosed
Send feedback